PHR - Phreesia, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/01/2023
31/01/2022
31/01/2021
31/01/2020
Total revenue
280,910
280,910
213,233
148,677
124,784
Cost of revenue
109,267
109,267
81,388
52,386
44,720
Gross profit
171,643
171,643
131,845
96,291
80,064
Operating expenses
Research development
91,244
91,244
52,265
22,622
18,623
Selling general and administrative
231,647
231,647
175,095
83,432
62,815
Total operating expenses
348,195
348,195
248,662
121,962
95,362
Operating income or loss
-176,552
-176,552
-116,817
-25,671
-15,298
Interest expense
1,411
1,411
1,163
-
-
Total other income/expenses net
-175
-175
-78
1
-4,330
Income before tax
-175,663
-175,663
-117,979
-27,243
-22,073
Income tax expense
483
483
182
49
-1,780
Income from continuing operations
-176,146
-176,146
-118,161
-27,292
-20,293
Net income
-176,146
-176,146
-118,161
-27,292
-20,293
Net income available to common shareholders
-176,146
-176,146
-118,161
-27,292
-91,423
Basic EPS
-
-
-2.37
-0.69
-4.50
Diluted EPS
-
-
-2.37
-0.69
-4.50
Basic average shares
-
-
49,888
39,520
20,301
Diluted average shares
-
-
49,888
39,520
20,301
EBITDA
-
-151,248
-95,515
-9,763
-1,374